Daniel H. Lachance

Mayo Clinic — United States

Medicine · Health Sciences

53h-index11.6kcitations329works3.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Glioma Diagnosis and Treatment(117), Radiomics and Machine Learning in Medical Imaging(32), Autoimmune Neurological Disorders and Treatments(23), Peripheral Neuropathies and Disorders(22), Meningioma and schwannoma management(21)

Publications328 total

DNA copy number patterns reveal prognostic markers and elucidate mechanisms of evolution in IDH-mutant astrocytoma
Neuro-Oncology·2026
Clinical Implications of Aberrant Retinoblastoma Signaling in Patients With Grade 4 IDH-Mutant Astrocytoma
Neurology·2025
Comparison of clinical, radiographic and genomic alterations between histologic and molecular glioblastoma, <i>IDH</i> -wildtype
Neuro-Oncology Advances·2025Open Access
Neural synaptic vesicle autoimmunity following aerosolized porcine neural tissue exposure: insights into autoimmune inflammatory polyradiculoneuropathy
EBioMedicine·2025Open Access
A Clinical Tool to Identify Incidental Meningioma for Early Outpatient Management
JAMA Oncology·2025Open Access
A framework for using DNA methylation-based modelling for the clinical management of cranial meningioma
Neuro-Oncology·2025Open Access
<i>SLC44A1::PRKCA</i> fusion-positive glioneuronal tumor without histological and epigenetic features of papillary glioneuronal tumor
Journal of Neuropathology & Experimental Neurology·2025
Prognostic factors and therapeutic outcomes in neurolymphomatosis: A 22-year cohort study from Mayo Clinic
Blood·2025
PATH-82. Multivariate survival risk stratification in GBMs lacking necrosis and microvascular proliferation
Neuro-Oncology·2025Open Access
INNV-50. Temozolomide for patients with PitNETs: a case series and literature review
Neuro-Oncology·2025Open Access
NCOG-29. Patient demographics and clinical outcomes in the rare diagnosis of mixed subependymoma/ependymoma: a retrospective single-institution study
Neuro-Oncology·2025Open Access
PATH-36. DNA copy number clustering reveals alterations that influence survival in primary IDH-mutant astrocytoma patients
Neuro-Oncology·2025Open Access
EPCO-26. HIGH-RESOLUTION PROFILING OF TELOMERE DYNAMICS AND GENOMIC VARIANTS IN ASTROCYTOMAS USING LONG-READ SEQUENCING
Neuro-Oncology·2025Open Access
PATH-104. Comparison of clinical, radiographic and genomic alterations between classic and molecular glioblastoma, IDH-wildtype (updated report)
Neuro-Oncology·2025Open Access
IMG-38. Differentiating adult diffuse IDH-mutant glioma from molecular glioblastoma IDH-wildtype using deep learning on MRI
Neuro-Oncology·2025Open Access
IMG-87. Differentiation of IDH-Wildtype Glioblastoma and Primary Central Nervous System Lymphoma Using 3D Deep Learning on MRI
Neuro-Oncology·2025Open Access
Evaluating the current neuro-oncology capacity in Sub-Saharan Africa: A questionnaire-based survey
Neuro-Oncology Practice·2025
P17.34.B BELZUTIFAN IN CLINICAL PRACTICE: OUTCOMES AND SAFETY IN A REAL-WORLD COHORT OF PATIENTS WITH VHL-ASSOCIATED NEOPLASMS
Neuro-Oncology·2025Open Access
Genomewide association study of a homogeneous multiple sclerosis cohort: Tumefactive demyelination
Multiple Sclerosis Journal·2025Open Access
Telehealth utilization in neuro-oncology: A single institution experience.
Journal of Clinical Oncology·2025
page 1 of 17Next →

Frequent Co-authors

Robert B. Jenkins(23), Caterina Giannini(19), Margaret Wrensch(17), Ho‐Keung Ng(15), Paul A. Decker(14), Jeanette E. Eckel‐Passow(13), John K. Wiencke(13), Kenneth Aldape(13), Farshad Nassiri(12), Terri Rice(11), Gelareh Zadeh(11), Thomas M. Kollmeyer(9), Arie Perry(9), Suganth Suppiah(9), Ian F. Dunn(9), Patrick Y. Wen(9), Lucie McCoy(8), Jill S. Barnholtz‐Sloan(8), Matthew Kosel(8), Nicholas Butowski(8)